Please contact info @ joyc.biz should you have any questions for below opportunity.

Funding Opportunity - US $ 3 million  

Exit Strategy - Acquisition

Potential ROI - Based on lab & ad revenue only

Potential Valuation with data  & diagnostics included in revenue - billions

OPPORTUNITY 

This is a women’s health research and diagnostics company, like no other.

The lack of data and diagnostics for evaluating women’s hormone-related conditions is a tremendous unmet need in the medical community. Over 100 million women suffer from hormone-related OB/Gyn conditions. Effective diagnostics do not exist; research and treatment options are limited.

• 70% of OB/Gyn clinical practice guidelines areareareare notnotnotnot based on evidence
• Time to diagnose common Gyn conditions: 5-10 years

The need for women's health data is critical.

SOLUTION

Crowdsource. Give women the tools they want and need to manage their own health; make it easy, social and fun. In return, we get revenue and the data needed to revolutionize women’s health. What we offer: 

• Affordable, salivary hormone measurement kits sold direct-to-consumer: recurring revenue.
• Free web-based, mobile accessible, health-record and symptom tracking platform: recurring data.
• Social network functionality: crowdsourcing.
• Data analytics for personal health, physician records, and Lucine research: recurring revenue.

VALUE MODEL

The colossal need and market for our products combined with the social networking functionality embedded in the system, promises tens of millions of unique page views,millions of Lucine Women community members, hundreds of thousands of hormone kits sold and millions of valuable datum. How it works:

Women purchase hormones tests; track their symptoms online for free, talk with other women and physicians.

Physicians and pharmacists subscribe to patient reports with hormone and symptom data, aggregated.

Clinical trials, physicians and companies advertise to a highly targeted, receptive, and very large market.

Companies purchase proprietary, de-identified data or subscribe to research services and infrastructure.

This company in Nevada develops diagnostics, patents and licenses to pharma, device or other companies.

REVENUE FORECAST

Lab Products & Target Health Advertising

• $13.7 million in revenue by the end of year two
• $82 million in revenue by year five

Big Data

This health data platform will collect massive quantities of symptom and hormone data; data that do not exist anywhere else in the world. The revenue possibilities leveraged with these data are enormous.

Imagine what a pharmaceutical or health insurance company might pay for these de-identified data.

IP Pipeline & Revenue

We plan to analyze the data, create high value clinical diagnostic algorithms and hormone monitoring tests, patent and license to reference labs, device and pharmaceutical companies. Then repeat, again and again.

Licensing and recurring royalty revenue fees portend millions in additional revenue beginning in years 4-5, without the hassles of manufacturing, sales or distribution.

Platform Technologies

Our health data aggregation platform is built on a multi-tiered system supported by a flexible and interchangeable UI, patient-controlled authorization and is compatible with emerging Health IT systems. The platform can be subscribed to or licensed for other functions.

Subscribers: compounding pharmacies, researchers, physicians

Licensees: pharma, researchers, governmental agencies